205 related articles for article (PubMed ID: 32700282)
61. Revisiting estrogen-dependent signaling pathways in endometriosis: Potential targets for non-hormonal therapeutics.
Kobayashi H; Kimura M; Maruyama S; Nagayasu M; Imanaka S
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():103-110. PubMed ID: 33421806
[TBL] [Abstract][Full Text] [Related]
62. Dual inhibition of AKT and ERK1/2 pathways restores the expression of progesterone Receptor-B in endometriotic lesions through epigenetic mechanisms.
Dutta S; Lee J; Banu SK; Arosh JA
Mol Cell Endocrinol; 2024 May; 592():112290. PubMed ID: 38825223
[TBL] [Abstract][Full Text] [Related]
63. Expression patterns of Aurora A and B kinases, Ki-67 and the estrogen and progesterone receptors determined using an endometriosis tissue microarray model.
Calcagno A; Grassi T; Mariuzzi L; Marzinotto S; Londero AP; Orsaria M; Beltrami CA; Marchesoni D
Hum Reprod; 2011 Oct; 26(10):2731-41. PubMed ID: 21840910
[TBL] [Abstract][Full Text] [Related]
64. Post-Transcriptional and Epigenetic Regulation of Estrogen Signaling.
Cignarella A; Boscaro C; Albiero M; Bolego C; Barton M
J Pharmacol Exp Ther; 2023 Sep; 386(3):288-297. PubMed ID: 37391222
[TBL] [Abstract][Full Text] [Related]
65. The many faces of estrogen signaling.
Vrtačnik P; Ostanek B; Mencej-Bedrač S; Marc J
Biochem Med (Zagreb); 2014; 24(3):329-42. PubMed ID: 25351351
[TBL] [Abstract][Full Text] [Related]
66. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
67. Endometrial stromal progesterone receptor-A/progesterone receptor-B ratio: no difference between women with and without endometriosis.
Gentilini D; Vigano P; Vignali M; Busacca M; Panina-Bordignon P; Caporizzo E; Di Blasio AM
Fertil Steril; 2010 Sep; 94(4):1538-1540. PubMed ID: 20097334
[TBL] [Abstract][Full Text] [Related]
68. Regulation of gene expression in the bovine mammary gland by ovarian steroids.
Connor EE; Meyer MJ; Li RW; Van Amburgh ME; Boisclair YR; Capuco AV
J Dairy Sci; 2007 Jun; 90 Suppl 1():E55-65. PubMed ID: 17517752
[TBL] [Abstract][Full Text] [Related]
69. Hormonally mediated epigenetic changes to steroid receptors in the developing brain: implications for sexual differentiation.
Nugent BM; Schwarz JM; McCarthy MM
Horm Behav; 2011 Mar; 59(3):338-44. PubMed ID: 20800064
[TBL] [Abstract][Full Text] [Related]
70. MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.
Rahman MM; Brane AC; Tollefsbol TO
Cells; 2019 Oct; 8(10):. PubMed ID: 31597272
[TBL] [Abstract][Full Text] [Related]
71. H3K27me3 is an Epigenetic Mark of Relevance in Endometriosis.
Colón-Caraballo M; Monteiro JB; Flores I
Reprod Sci; 2015 Sep; 22(9):1134-42. PubMed ID: 25820690
[TBL] [Abstract][Full Text] [Related]
72. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B.
Chi S; Liu Y; Zhou X; Feng D; Xiao X; Li W; Zhao Y; Wang H
Cancer Chemother Pharmacol; 2019 Feb; 83(2):277-287. PubMed ID: 30443761
[TBL] [Abstract][Full Text] [Related]
73. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
74. miRNA as a New Regulatory Mechanism of Estrogen Vascular Action.
Pérez-Cremades D; Mompeón A; Vidal-Gómez X; Hermenegildo C; Novella S
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415433
[TBL] [Abstract][Full Text] [Related]
75. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
76. Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifen.
Bhattacharyya N; Ramsammy R; Eatman E; Hollis VW; Anderson WA
J Submicrosc Cytol Pathol; 1994 Apr; 26(2):147-62. PubMed ID: 8019941
[TBL] [Abstract][Full Text] [Related]
77. Epigenetic dysregulation of endometriosis susceptibility genes (Review).
Koike N; Higashiura Y; Akasaka J; Uekuri C; Ito F; Kobayashi H
Mol Med Rep; 2015 Aug; 12(2):1611-6. PubMed ID: 25891066
[TBL] [Abstract][Full Text] [Related]
78. The loss of estrogen and progesterone receptor gene expression in human breast cancer.
Lapidus RG; Nass SJ; Davidson NE
J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):85-94. PubMed ID: 10819507
[TBL] [Abstract][Full Text] [Related]
79. The role of epigenetic changes in preeclampsia.
Kamrani A; Alipourfard I; Ahmadi-Khiavi H; Yousefi M; Rostamzadeh D; Izadi M; Ahmadi M
Biofactors; 2019 Sep; 45(5):712-724. PubMed ID: 31343798
[TBL] [Abstract][Full Text] [Related]
80. A current view of the role of epigenetic changes in the aetiopathogenesis of endometriosis.
Kokcu A
J Obstet Gynaecol; 2016; 36(2):153-9. PubMed ID: 26467001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
